Mintz

We’re proud to announce that Mintz has been named a finalist for three awards by LSPN, which honor firms and individuals redefining excellence in life sciences IP. ✨ Life Sciences IP Firm of the Year ✨ Life Sciences IP Litigation Firm of the Year ✨ Siegmund (Sige) Gutman, Patent Litigator of the Year Judged by an independent panel, the Life Sciences IP Review's LSPN Awards celebrate trailblazers across the industry. Congratulations to our IP team and to Siegmund Gutman on this well earned recognition. https://lnkd.in/egTRyHCJ

We’re honored to once again sponsor and attend the 2026 Massachusetts Black Lawyers Association Annual Gala. This event plays an important role in strengthening the Black legal community, fostering meaningful connections across the Boston legal landscape, and creating opportunities to recognize and elevate Black attorneys and leaders. Our participation reinforces our commitment to inclusion in the legal profession and for being an active part of the communities we serve. We look forward to joining this year’s celebration and continuing our partnership! https://lnkd.in/e44DbWS7

“I try to lead with empathy, and I try to be conscientious… overall, I want people to feel respected, and I want them to feel valued.”    Employment Chair Michael Arnold joined Elise Powers on the Corner Office podcast to talk about gratitude, leadership, and building a people-first culture.    If you want a quick, thoughtful look at what authentic leadership looks like in practice, this episode is worth a watch. https://lnkd.in/e2p4WQQa  

Members of our Sustainable Energy and Infrastructure practice were on the ground at the Infocast Solar + Wind Finance & Investment Summit, joining the developers, investors, and financing leaders shaping the clean energy landscape. Adam Banack, Kristopher Kirkwood, Ayaz Shaikh, and Luis Frank Torres spent their time at the Summit exchanging ideas, sharing perspectives, and strengthening connections across the clean energy ecosystem. Conversations like these are what keep us — and our clients — ahead of what’s next in the market.

Most private equity funds include clawback mechanisms but applying them in practice can present complex challenges. On an upcoming Strafford (Now BARBRI) webinar, Member Ruth Jin will cover how carried interest clawbacks work in private equity funds, including common structures, how distributions are handled, and the related tax implications. She and her co-panelists will offer practical guidance for practitioners representing funds and investors. Program details: https://lnkd.in/eUjhnchh #investmentfunds #privatefunds #privateequity #carry #clawbacks

Health care enforcement is changing fast. In this year’s edition of EnforceMintz, our health care enforcement defense attorneys break down the biggest trends of 2025 and highlight the emerging priorities that will define 2026. With Medicare Advantage facing heightened scrutiny, ongoing FCA litigation, and mounting regulatory uncertainty, health care organizations need experienced counsel to navigate increasing enforcement risk and protect their operations in an ever more complex Medicare Advantage landscape. Read the full report: https://lnkd.in/eWm8EiqK #HealthCareEnforcement #HealthLaw #EnforceMintz

We are proud to have represented the underwriters in SAB Biotherapeutics’ $85 million public offering. The Mintz Capital Markets team included William Hicks, John Rudy, Alok Choksi, Hannah Karraker, Gretchen Goyette, Paty Garza Gonzalez, and Kate McLeod. Ari Feder advised on tax matters, Yahua (Jenny) Chen advised on intellectual property matters, and Joanne Hawana advised on regulatory matters.

We were pleased to advise Swarmer (Nasdaq: SWMR), a drone autonomy software company supporting operations in Ukraine, on its successful initial public offering on the Nasdaq. Swarmer issued 3,000,000 shares of common stock at a public offering price of $5.00 per share, for expected gross proceeds of approximately $15 million before underwriting discounts, commissions, and expenses. The offering closed with the full exercise of the underwriters’ over-allotment option, bringing total shares sold to 3,450,000 for gross proceeds of $17.25 million. The Mintz team was led by Members Ken Koch and Daniel Bagliebter, with support from Associates Kostantinos Skordalos, Hannah Karraker, Patricia Gonzalez, and Kate McLeod. https://lnkd.in/e-7sRhsV

Ready to sharpen your dealmaking edge? Join Mintz and the Boston Chapter of LES USA & Canada for two fast-moving panels exploring the latest trends in life sciences transactions and the key issues shaping today’s biopharma licensing landscape. Panel 1: Structuring Your Life Sciences Transaction in 2026: Licensing vs. M&A vs. Options to Buy vs. Asset Sale  A practical conversation on selecting the most effective deal structure for your goals — from licensing to M&A, options to buy, and asset sales — and what large biopharma companies prioritize when evaluating potential partnerships and acquisition paths. Panel 2: Navigating Licensing Deals Involving Chinese Life Sciences Assets: Strategies, Challenges, and Opportunities   A focused overview of the regulatory and commercial factors shaping China-related licensing — plus emerging trends as Chinese biotechs expand their roles as global licensors. 🗓️ Thursday, April 16, 2026 🕙 3:00 pm – 7:00 pm 📍 Mintz | One Financial Center, Boston This program is ideal for C-suite executives, founders, business development leaders, in-house counsel, scientists with BD responsibilities, tech transfer professionals, investors, and global teams evaluating China-facing opportunities. 👉 Join us for actionable insights and strategic perspectives from experienced dealmakers: https://lnkd.in/espRSTcR

Congratulations to our client Sixth Street and co‑investor Blackstone Credit & Insurance on the successful closing of a $1.3 billion financing supporting the combination of Paratek Pharmaceuticals and Radius Health, creating a scaled, multi‑product specialty pharmaceutical company backed by B‑FLEXION Life Sciences. The combination brings together the commercial portfolios of Paratek, including NUZYRA® and XHANCE®, and Radius, including TYMLOS®, to create a diversified specialty pharmaceutical portfolio expected to generate nearly $1 billion in annual revenue in 2026. Grateful for the outstanding collaboration across our Mintz team: Tali Tuchin, Eric Blythe, Joanne Hawana, Peter Hecker, Christine Pemberton, and Joshua S Li. https://lnkd.in/e7stFgfk